BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bloechliger M, Rüegg S, Jick SS, Meier CR, Bodmer M. Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis. CNS Drugs 2015;29:591-603. [PMID: 26242478 DOI: 10.1007/s40263-015-0262-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Harbell MW, Dumitrascu C, Bettini L, Yu S, Thiele CM, Koyyalamudi V. Anesthetic Considerations for Patients on Psychotropic Drug Therapies. Neurol Int 2021;13:640-58. [PMID: 34940748 DOI: 10.3390/neurolint13040062] [Reference Citation Analysis]
2 Orsolini L, Tomasetti C, Valchera A, Vecchiotti R, Matarazzo I, Vellante F, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Mazza M, Perna G, Carano A, De Bartolomeis A, Di Giannantonio M, De Berardis D. An update of safety of clinically used atypical antipsychotics. Expert Opin Drug Saf 2016;15:1329-47. [PMID: 27347638 DOI: 10.1080/14740338.2016.1201475] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 11.7] [Reference Citation Analysis]
3 Habibi M, Hart F, Bainbridge J. The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs. Curr Neurol Neurosci Rep 2016;16. [DOI: 10.1007/s11910-016-0670-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
4 Monteith S, Glenn T, Geddes J, Whybrow PC, Bauer M. Big data for bipolar disorder. Int J Bipolar Disord 2016;4:10. [PMID: 27068058 DOI: 10.1186/s40345-016-0051-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
5 Man KKC, Lau WCY, Coghill D, Besag FMC, Cross JH, Ip P, Wong ICK. Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study. Lancet Child Adolesc Health 2020;4:435-43. [PMID: 32450123 DOI: 10.1016/S2352-4642(20)30100-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Phillips J, Lim F, Hsu R. The emerging threat of synthetic cannabinoids. Nursing Management 2017;48:22-30. [DOI: 10.1097/01.numa.0000512504.16830.b6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Jeon SM, Park S, Kim D, Kwon JW. Risk of seizures associated with antipsychotic treatment in pediatrics with psychiatric disorders: a nested case-control study in Korea. Eur Child Adolesc Psychiatry 2021;30:391-9. [PMID: 32266577 DOI: 10.1007/s00787-020-01525-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alfageh BH, Besag FMC, Gao L, Ma TT, Man KKC, Wong ICK, Brauer R. Antipsychotic Medication and Risk of Incident Seizure in People with Autism Spectrum Disorder: Analyses with Cohort and Within Individual Study Designs. J Autism Dev Disord 2021. [PMID: 34751867 DOI: 10.1007/s10803-021-05208-0] [Reference Citation Analysis]
9 Adachi N, Ito M. Epilepsy in patients with schizophrenia: Pathophysiology and basic treatments. Epilepsy Behav 2022;127:108520. [PMID: 34999502 DOI: 10.1016/j.yebeh.2021.108520] [Reference Citation Analysis]
10 Ijaz S, Bolea B, Davies S, Savović J, Richards A, Sullivan S, Moran P. Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews. BMC Psychiatry 2018;18:275. [PMID: 30176844 DOI: 10.1186/s12888-018-1848-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
11 Kirsten A, Linder S, Olbrich S. [Perspectives for the Electroencephalogram in Psychiatry]. Praxis (Bern 1994) 2018;107:837-43. [PMID: 30043707 DOI: 10.1024/1661-8157/a003028] [Reference Citation Analysis]
12 Sarma AK, Khandker N, Kurczewski L, Brophy GM. Medical management of epileptic seizures: challenges and solutions. Neuropsychiatr Dis Treat 2016;12:467-85. [PMID: 26966367 DOI: 10.2147/NDT.S80586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
13 Kintz P, Ameline A, Raul JS. Promazine Detection in Human Hair: Presentation of a LC-MS/MS Method and Pattern of Drug Discontinuation. J Anal Toxicol 2021:bkab101. [PMID: 34518883 DOI: 10.1093/jat/bkab101] [Reference Citation Analysis]
14 Vetrichevvel TP, Randall SM, Fear MW, Wood FM, Boyd JH, Duke JM. Burn injury and long-term nervous system morbidity: a population-based cohort study. BMJ Open 2016;6:e012668. [PMID: 27609857 DOI: 10.1136/bmjopen-2016-012668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
15 Jacob L, Bohlken J, Schmitz B, Kostev K. Incidence of epilepsy and associated factors in elderly patients in Germany. Epilepsy Behav 2019;90:107-11. [PMID: 30529258 DOI: 10.1016/j.yebeh.2018.10.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Gruntz K, Bloechliger M, Becker C, Jick SS, Fuhr P, Meier CR, Rüegg S. Parkinson disease and the risk of epileptic seizures: PD and Epileptic Seizures. Ann Neurol 2018;83:363-74. [DOI: 10.1002/ana.25157] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
17 Perugi G, De Rossi P, Fagiolini A, Girardi P, Maina G, Sani G, Serretti A. Personalized and precision medicine as informants for treatment management of bipolar disorder. Int Clin Psychopharmacol 2019;34:189-205. [PMID: 30932919 DOI: 10.1097/YIC.0000000000000260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 Ralph SJ, Espinet AJ. Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care. J Alzheimers Dis Rep 2018;2:1-26. [PMID: 30480245 DOI: 10.3233/ADR-170042] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
19 Beeber AS, Zimmerman S, Wretman CJ, Palmertree S, Patel K, Sloane PD. Potential Side Effects and Adverse Events of Antipsychotic Use for Residents With Dementia in Assisted Living: Implications for Prescribers, Staff, and Families. J Appl Gerontol 2021;:7334648211023678. [PMID: 34160299 DOI: 10.1177/07334648211023678] [Reference Citation Analysis]
20 Druschky K, Bleich S, Grohmann R, Engel RR, Neyazi A, Stübner S, Toto S. Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project. World J Biol Psychiatry 2019;20:732-41. [PMID: 30058414 DOI: 10.1080/15622975.2018.1500030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]